Accenture invests in intelligent transcriptome firm Ocean Genomics
Accenture has announced an investment in intelligent transcriptome firm Ocean Genomics through its Accenture Ventures unit in an effort to expedite artificial intelligence (AI)-driven drug discovery. The terms